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Background
Cardiotoxicity from cancer chemotherapy is an important
cause of morbidity and mortality in breast cancer survi-
vors. Left ventricular (LV) systolic dysfunction due to
sequential use of anthracyclines and trastuzumab has been
reported in up to 20-25% of patients. The pathophysio-
logical changes associated with LV dysfunction have not
been described non-invasively. We performed cardiac MRI
(cardiac MR) with T2 mapping to assess whether myocar-
dial edema is a feature of acute cardiotoxicity in women
with breast cancer receiving sequential anthracyclines and
trastuzumab.
Methods
We prospectively recruited women with HER2+ breast
cancer scheduled to receive anthracyclines followed by
trastuzumab (Grp A) and patients during therapy with
anthracyclines and trastuzumab who were diagnosed
with subclinical cardiac toxicity (Grp B) using multi-gated
acquisition scans (MUGA) based on Cardiac Review and
Evaluation Committee’s criteria. All patients (July to Aug
2013) underwent cardiac MR imaging at 1.5 Tesla with
conventional steady state free precession cine and late
gadolinium enhancement (LGE) imaging with addition of
quantitative T2 mapping using a T2-prepared single-shot
SSFP technique. LV volumes and systolic function were
quantified and segmental T2 values for all 16 myocardial
segments were obtained from basal, mid, and apical short
axis views. T2 values > 59 ms were considered abnormal
based on previously published data. Mann-Whitney rank
sum test was used for comparisons.
Results
Preliminary results: Patients in Grp A (n = 6, age 44 ± 8
years) had higher LVEF than patients in Grp B (n = 3,
age 50 ± 9 years) - 59 ± 7% vs. 49 ± 5%; p = 0.02.
While all segments (n = 96; 100%) in patients in Grp A
showed T2 values < 59 ms with a mean of 53.6 ± 2.9 ms
(47.5-58.8 ms), in patients in Grp B 14/48 segments (29%)
showed abnormal T2 values > 59 ms with a mean of 63.5
± 4.2 ms (59.4-70.9 ms); p < 0.001. The remaining 34
segments in patients in Grp B demonstrated T2 values
< 59% with a mean of 55.2 ± 2.3 ms. Two out of the
3 patients in Grp B had minimal mid-myocardial scar on
LGE imaging. Figures 1 and 2 illustrate T2 values in a
patient in Grp A and Grp B respectively.
Conclusions
This preliminary analysis of a larger ongoing study
demonstrates significant increase in segmental T2 values
in breast cancer patients with cardiotoxicity compared
to those pre-initiation of chemotherapy. This suggests
that myocardial edema may be a feature of cardiotoxicity
that results from treatment with sequential anthracy-
clines and trastuzumab. Whether quantitative assessment
of myocardial edema early during therapy can predict
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subsequent development of cardiotoxicity remains to be
determined.
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Figure 1 T2 maps in for a patient pre-initiation of therapy. The mean T2 values for each segment and the standard deviation (mean/
standard deviation ms) are shown and were all within normal values. The images represent (A) basal, (B) mid, and (C) apical short axis T2 maps.
LVEF in this patient was 57%.
Figure 2 (A-C) Segmental T2 values (mean/standard deviation) for the (A) basal, (B) mid, and (C) apical myocardial segments in a
patient with cardiotoxicity. There were 7 segments with abnormal T2 values (defined as T2 values > 59 ms). Mean T2 values of the abnormal
segments was 62.3 ms. LVEF in this patient was 46% (from 63% pre therapy).
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